Prescient Therapeutics develops personalised therapies to conquer cancer. It has a broad portfolio of well advanced assets developed with world-leading partners ...
INVESTOR PORTAL. Here you will find ASX announcements and share price data, along with other key company information. You can also subscribe for email updates ...
Prescient Therapeutics Ltd (ASX:PTX, OTC:PSTTF) will present results of its Phase 1b study of PTX-100 in T-cell lymphomas during a poster presentation .
Missing: relations | Show results with:relations
We are Partner Therapeutics · PTx is a commercial biopharmaceutical company committed to improving the lives of patients with cancer and other serious diseases.
PTX Metals Inc. creates shareholder value through the opportunistic acquisition and advancement of high-quality projects in prolific Ontario mining camps.
Apr 7, 2024 · Join Prescient Therapeutics CEO & MD Steven Yatomi-Clarke for an online investor briefing on Tuesday, 9 April at 2pm (AEST).
Missing: relations | Show results with:relations
Read the latest Company Report General news from Prescient Therapeutics Limited (ASX:PTX)
Investors · Stock Information · Corporate Presentation · Financial Statements · Notice and Access · Cautionary Notes.
Missing: relations | Show results with:relations
In this session, Steven will discuss: How PTX is taking the cancer treatment conversation from 'fight' to 'cure'; How the company can potentially make any CAR-T ...
Missing: relations | Show results with:relations
Mar 27, 2024 · This is "Reach Markets: Prescient Therapeutics (ASX: PTX) Investor Briefing Q&A - 25th March 2024 (RM)" by Reach Markets on Vimeo, ...